September 16, 2014

First-in-human study of novel integrin receptor PET tracer

The first PET imaging study of its kind to show the viability of tumor angiogenesis imaging in humans with investigational Ga-68 NODAGA-Theranost has been conducted by researchers from the Theranostics Center for Molecular Radiotherapy and Molecular Imaging in Bad Berka, Germany, and other institutions including the National Cancer Institute and Advanced Imaging projects based in Boca Raton, Fla. Molecular Imaging has obtained an exclusive sneak-peek at the study. {read more here}